Literature DB >> 8620126

Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994.

G G Giles1, B K Armstrong, R C Burton, M P Staples, V J Thursfield.   

Abstract

OBJECTIVE: To describe recent trends in mortality from melanoma in Australia.
DESIGN: An analysis of trends in age standardised and age and sex specific mortalities by year of death and median year of birth (cohort).
SETTING: Australia.
SUBJECTS: All deaths from melanoma registered in Australia between 1931 and 1994.
RESULTS: Melanoma mortality rose steadily from 1931 to 1985. From 1959 the annual rate of increase was 6.3% in men and 2.9% in women, resulting in mortalities of 4.82 and 2.51 per 100,000 person years in 1985 and 1989, respectively. Mortalities for both sexes seem to have plateaued from June 1985 onwards. In 1990-4 the rate rose by 3.7% in men to 5.00 per 100,000 and in women it fell by 5.2% to 2.38 per 100,000. The non-significant increase after 1985 in mortality in men was restricted to those aged over 70 years of age, whereas the fall in rates in women was mostly in those aged under 55 years. This pattern was generally reflected in the state trends, though with some variation: rates for women in Queensland had peaked in the late 1970s; while rates for men in New South Wales continued to rise in 1990-4, placing them above those for Queensland. Examination of mortalities specific for age, period, and cohort for Australia as a whole showed several salient features. Rates in men rose steeply in cohorts born before about 1930; were stable in cohorts born between 1930 and 1950; and fell in more recent cohorts. Rates in women showed similar changes but about five years earlier.
CONCLUSION: Melanoma mortality in Australia peaked in about 1985 and has now plateaued. On the basis of trends in cohorts it can be expected to fall in coming years.

Entities:  

Mesh:

Year:  1996        PMID: 8620126      PMCID: PMC2350656          DOI: 10.1136/bmj.312.7039.1121

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  24 in total

1.  International trends in cutaneous melanoma.

Authors:  A J Swerdlow
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Epidemiological features of melanoma in South Australia: implications for cancer control.

Authors:  A Bonett; D Roder; A Esterman
Journal:  Med J Aust       Date:  1989-11-06       Impact factor: 7.738

3.  Trends in mortality from melanoma in Australia.

Authors:  B K Armstrong; C M Howell
Journal:  Med J Aust       Date:  1987-08-03       Impact factor: 7.738

4.  Cohort analysis of malignant melanoma in five countries.

Authors:  D J Venzon; S H Moolgavkar
Journal:  Am J Epidemiol       Date:  1984-01       Impact factor: 4.897

5.  Incidence and reporting of cutaneous melanoma in Queensland.

Authors:  A Green
Journal:  Australas J Dermatol       Date:  1982-12       Impact factor: 2.875

6.  Queensland melanoma project: organization and a plea for comparable surveys.

Authors:  N C Davis; J J Herron
Journal:  Med J Aust       Date:  1966-04-09       Impact factor: 7.738

7.  Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma.

Authors:  C D Holman; B K Armstrong
Journal:  J Natl Cancer Inst       Date:  1984-02       Impact factor: 13.506

8.  Changing trends in the epidemiology of malignant melanoma: gender differences and their implications for public health.

Authors:  A Streetly; H Markowe
Journal:  Int J Epidemiol       Date:  1995-10       Impact factor: 7.196

9.  Melanoma in new South Wales 1970-1976. Confirmation of increased incidence.

Authors:  W H McCarthy; A L Martyn; G Roberts; A J Dobson
Journal:  Med J Aust       Date:  1980-08-09       Impact factor: 7.738

10.  An analysis of trends in mortality from malignant melanoma of the skin in Australia.

Authors:  C D Holman; I R James; P H Gattey; B K Armstrong
Journal:  Int J Cancer       Date:  1980-12-15       Impact factor: 7.396

View more
  12 in total

1.  [Prevention of skin cancer. Necessity, implementation and success].

Authors:  R Greinert; B Volkmer; A Wende; S Voss; E W Breitbart
Journal:  Hautarzt       Date:  2003-12       Impact factor: 0.751

2.  Melanoma: A new strategy to reduce morbidity and mortality.

Authors:  Cameron Williams; Christopher Quirk; Anna Quirk
Journal:  Australas Med J       Date:  2014-07-31

Review 3.  Malignant melanoma (non-metastatic): sentinel lymph node biopsy.

Authors:  Andy Pay
Journal:  BMJ Clin Evid       Date:  2016-01-19

Review 4.  Malignant melanoma (non-metastatic).

Authors:  Philip Savage
Journal:  BMJ Clin Evid       Date:  2007-06-01

5.  Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients.

Authors:  S Kruijff; E Bastiaannet; A B Francken; M Schaapveld; M van der Aa; H J Hoekstra
Journal:  Br J Cancer       Date:  2012-06-19       Impact factor: 7.640

6.  The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study.

Authors:  J Melia; S Moss; D Coleman; T Frost; R Graham-Brown; J A Hunter; R A Marsden; A du Vivier; A P Warin; J White; S M Whitehead; M A Wroughton
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

7.  Mortality from cutaneous melanoma: evidence for contrasting trends between populations.

Authors:  G Severi; G G Giles; C Robertson; P Boyle; P Autier
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

Review 8.  Sociodemographic and Psychological Correlates of Sun Protection Behaviors among Outdoor Workers: A Review.

Authors:  Vinayak K Nahar; M Allison Ford; Jeffrey S Hallam; Martha A Bass; Michael A Vice
Journal:  J Skin Cancer       Date:  2013-10-22

Review 9.  Modifiable risk factors for cancer.

Authors:  C J Stein; G A Colditz
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

10.  Mortality due to cutaneous melanoma in south region of Brazil: a spatial approach.

Authors:  Flávia Regina Ferreira; Luiz Fernando Costa Nascimento
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.